Uncommon and recently described renal carcinomas

Modern Pathology

Volumn 22, Issue , 2009, Pages S2-S23

  Srigley, John R ^a,b   Delahunt, Brett ^b  

^a MCMASTER UNIVERSITY   (Canada)

^b UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Collecting duct carcinoma; Medullary carcinoma; Mucinous tubular and spindle cell carcinoma; Neuroblastoma; Renal carcinoma; Translocation carcinoma

Indexed keywords

CYTOKERATIN 20; CYTOKERATIN 7;

CANCER CLASSIFICATION; CANCER DIAGNOSIS; CANCER GROWTH; CANCER LOCALIZATION; CANCER SIZE; CANCER SURVIVAL; CANCER SURVIVOR; CHILDHOOD CANCER; CHROMOSOME TRANSLOCATION; CLEAR CELL CARCINOMA; COLLECTING DUCT CARCINOMA; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; FAMILIAL CANCER; FOLLICULAR CARCINOMA; HISTOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; KIDNEY COLLECTING TUBULE; KIDNEY FAILURE; KIDNEY MEDULLA; KIDNEY TUBULE; LEIOMYOMA; MEDULLARY CARCINOMA; MUCINOUS CARCINOMA; NEPHRECTOMY; NEUROBLASTOMA; ONCOCYTIC PAPILLARY RENAL CELL CARCINOMA; PAPILLARY CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SICKLE CELL TRAIT; SPINDLE CELL; SPINDLE CELL CARCINOMA; TRANSLOCATION CARCINOMA; TUBULOCYSTIC CARCINOMA; UROGENITAL TRACT TUMOR; WORLD HEALTH ORGANIZATION;

CARCINOMA; HUMANS; KIDNEY NEOPLASMS;

EID: 67149123373     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.2009.70     Document Type: Article

References (119)

1. Delahunt B, Eble JN. History of the development of the classification of renal cell neoplasia. Clin Lab Med 2005;25:231-246.
2. Kovacs G, Akhtar M, Beckwith JB, et al. The Heidelberg classification of renal cell tumours. J Pathol 1997;183:131-133.
3. Störkel S, Eble JN, Adlakha K, et al. Classification of renal carcinoma. Cancer 1997;80:987-989.
4. Eble JN, Sauter G, Epstein JI, et al. (eds). World Heatlh Organization Classification of Tumours. Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs. IARC Press: Lyon, 2004.
5. Foot NC, Papanicolaou GN. Early renal carcinoma in situ detected by means of smears of fixed urinary sediment. JAMA 1949;139:356-358.
6. Fleming S, Lewi HJE. Collecting duct carcinoma of the kidney. Histopathology 1986;10:1131-1141.
7. Kennedy SM, Meriino MJ, Linehan WM, et al. Collecting duct carcinoma of the kidney. Hum Pathol 1990;21:449-456.
8. Rumpelt HJ, Störkel S, Moll R, et al. Bellini duct carcinoma: further evidence for this rare variant of renal cell carcinoma. Histopathology 1991;18: 115-122.
9. Carter MD, Tha S, McLoughlin MG, et al. Collecting duct carcinoma of the kidney: a case report and review of the literature. J Urol 1992;147:1096-1198.
10. Füzesi L, Cober M, Mittermayer C. Collecting duct carcinoma: cytogenetic characterization. Histopathology 1992;21:155-160.
11. Bielsa O, Arango O, Corominas JM, et al. Collecting duct carcinoma of the kidney. Br J Urol 1994;74: 127-128. 12
12. Cavazzana AO, Prayer-Galetti T, Tirabosco R, et al. Bellini duct carcinoma, a clinical and in vitro study. Eur Urol 1996;30:340-344.
13. Delahunt B, Eble JN. Renal cell neoplasia. Pathology 2002;34:13-20.
14. Srigley JR, Eble JN. Collecting Duct Carcinoma of Kidney. Semin Diagn Pathol 1998;15:54-67.
15. Halenda G, Jr. Sees JN, Belis JA, et al. Atypical renal adenocarcinoma with features suggesting collecting duct origin and mimicking a mucinous adenocarcinoma. Urology 1998;41:165-168.
16. Dimopoulos MA, Logothetis CJ, Markowitz A, et al. Collecting duct carcinoma of the kidney. Br J Urol 1993;71:388-391.
17. Kobayashi N, Matsuzaki O, Shirai S, et al. Colelcting duct carcinoma of the kidneys: an immunohistochemical evaluation of the use of antibodies for differential diagnosis. Hum Pathol 2008;39: 1350-1359.
18. Schoenberg M, Cairns P, Brooks JD, et al. Frequent loss of chromosome arms 8p and 13q in collecting duct carcinoma (CDC) of the kidney. Genes Chromosomes Cancer 1995;12:76-80.
19. Orsola A, Trias I, Raventoś CX, et al. Renal collecting (Bellini) duct carcinoma displays similar characteristics to upper tract urothelial cell carcinoma. J Urol 2005;65:49-54.
20. Gupta R, Balzar B, Picken M, et al. Diagnostic implications of transcription factor Pax 2 protein and transmembrane enzyme complex carbonic anhydrase IX immunoreactivity in adult renal epithelial neoplasms. Am J Surg Pathol 2009;33:241-247.
21. Tokuda N, Naito S, Matsuzaki O, et al. Collecting duct (Bellini duct) renal cell carcinoma in Japan: a nationwide survey in Japan. J Urol 2006;176:40-43.
22. Davis CJ, Mostofi FK, Sesterhenn IA. Renal medullary carcinoma: The seventh sickle cell nephropathy. Am J Surg Pathol 1995;19:1-11.
23. Berman LB. Sickle cell nephropathy. JAMA 1974;228:1279.
24. Swartz MA, Karth J, Schneider DT, et al. Renal medullary carcinoma: clinical, pathologic, immunohistochemical and genetic analysis with pathogenetic implications. Urology 2002;60:1083-1089.
25. Yang XJ, Sugimura J, Tretiakova MS, et al. Gene expression profiling of renal medullary carcinoma: potential clinical relevance. Cancer 2004;100: 976-985.
26. Simpson L, He X, Pins M, et al. Renal medullary carcinoma and ABL gene amplification. J Urol 2005;173:1883-1888.
27. Sathyamoorthy K, Teo A, Atallah M. Renal medullary carcinoma in a patient with sickle-cell disease. Nature Clin Pract Urol 2006;3:279-283.
28. Leitao VA, da Silva W, Ferreira U, et al. Renal medullary carcinoma. Case report and review of the literature. Urol Int 2006;77:184-186.
29. Baig MA, Lin Y-S, Rasheed J, et al. Renal medullary carcinoma. J Natl Med Assoc 2006;98:1171-1174.
30. Hakimi AA, Koi PT, Milhoua PM, et al. Renal medullary carcinoma: The Bronx experience. Urology 2007;70:878-882.
31. Watanabe IC, Billis A, Guimaraes MS, et al. Renal medullary carcinoma: report of seven cases from Brazil. Mod Pathol 2007;20:914-920.
32. Cheng JX, Tretiakova M, Gong C, et al. Renal medullary carcinoma: rhabdoid features and the absence of INI1 expression as markers of aggressive behavior. Mod Pathol 2008;21:647-652.
33. Wartchow EP, Trost BA, Tucker JA, Albano EA, Mierau GW. Renal medullary carcinoma: ultrastructural studies may benefit diagnosis. Ultrastruct Pathol 2008;32:252-256.
34. Stahlschmidt J, Cullinane C, Roberts P, Picton SV. Renal medullary carcinoma: prolonged remission with chemotherapy, immunohistochemical chararcterisation and evidence of bcr/abl rearrangement. Med Pediatr Oncol 1999;33:551-557.
35. Weber A, Srigley J, Moch H. Muzinöses, tubuläres und spindelzelliges nierenkarzinom. Pathologie 2003;24:453-459.
36. MacLennan GT, Farrow GM, Bostwick DG. Low-grade collecting duct carcinoma of the kidney: report of 13 cases of low-grade mucinous tubulocystic renal carcinoma of possible collecting duct origin. Urology 1997;50:679-684.
37. Srigley JR, Eble JN, Grignon DJ, Hartwick RWJ. Unusual renal cell carcinoma (RCC) with prominent spindle cell change possibly related to the loop of Henle. Mod Pathol 1999;12:107A.
38. Srigley JR, Kapusta L, Reuter V, et al. Phenotypic, molecular and ultrastructural studies of a novel low grade renal epithelial neoplasm possibly related to the loop of Henle. Mod Pathol 2002;15:182A.
39. Parwani AV, Husain AN, Epstein JI, Beckwith JB, Argani P. Low-grade myxoid renal epithelial neoplasms with distal nephron differentiation. Hum Pathol 2001;32:506-512.
40. Rakozy C, Schmahl GE, Bogner S, Störkel S. Lowgrade tubular-mucinous renal neoplasms: morphologic, immunohistochemical and genetic features. Mod Pathol 2002;15:1162-1171.
41. Hes O, Hora M, Perez-Montiel DM, et al. Spindle and cuboidal renal cell carcinoma, a tumour having frequent association with nephrolithiasis:report of 11 cases including a case with hybrid conventional renal cell carcinoma/spindle and cuboidal renal cell carcinoma components. Histopathology 2002;41: 549-555.
42. Ferlicot S, Allory Y, Compérat E, et al. Mucinous tubular and spindle cell carcinoma: a report of 15 cases and a review of the literature. Virchows Arch 2005;447:978-983.
43. Shen SS, Ro JY, Tamboli P, et al. Mucinous tubular and spindle cell carcinoma of kidney is probably a variant of papillary renal cell carcinoma with spindle cell features. Ann Diagn Pathol 2007;11:13-21.
44. Fine SW, Argani P, DeMarzo AM, et al. Expanding the histologic spectrum of mucinous tubular and spindle cell carcinoma of the kidney. Am J Surg Pathol 2006;30:1554-1560.
45. Kuroda N, Nakamura S, Miyazaki E, et al. Low-grade tubular-mucinous renal neoplasm with neuroendocrine differentiation: A histological, immunohistochemical and ultrastructural study. Pathol Int 2004;54:201-207.
46. Dhillon J, Amin MB, Selbs E, et al. Mucinous tubular and spindle cell carcinoma of the kidney with sarcomatoid change. Am J Surg Pathol 2009;33: 44-49.
47. Pillay N, Ramdial PK, Cooper K, Batuule D. Mucinous tubular and spindle cell carcinoma with aggressive histomorphology-a sarcomatoid variant. Hum Pathol 2008;39:966-969.
48. Simon RA, di Sant’agnese PA, Palapattu GS, et al. Mucinous tubular and spindle cell carcinoma of the kidney with sarcomatoid differentiation. Int J Clin Exp Pathol 2008;1:180-1844.
49. Kuehn A, Paner GP, Skinnider BF, et al. Expression analysis of kidney-specific cadherin in a wide spectrum of traditional and newly recognized renal epithelial neoplasms: diagnostic and histogenetic implications. Am J Surg Pathol 2007;31:1528-1533.
50. Paner GP, Srigley JR, Radhakrishnan A, et al. Immunohistochemical analysis of mucinous tubular and spindle cell carcinoma and papillary renal cell carcinoma of the kidney. Am J Surg Pathol 2006;30:13-19.
51. Brandal P, Lie AK, Bassarova A, et al. Genomic aberrations in mucinous tubular and spindle cell renal cell carcinomas. Mod Pathol 2005;19: 186-194.
52. Cossu-Rocca P, Eble JN, Delahunt B, et al. Renal mucinous tubular and spindle carcinoma lacks the gains of chromosomes 7 and 17 and losses of chromosome Y that are prevalent in papillary renal cell carcinoma. Mod Pathol 2006;19:488-493.
53. Srigley JR. Mucinous tubular and spindle cell carcinoma WHO classification of tumors In: Eble JN, Sauter G, Epstein JI, Sesterhenn IA (eds). Tumors of the Genito-urinary and Male Genital Organs. IARC Press: IARC, Washington DC, 2004.
54. Argani P, Netto GJ, Parwani AV. Papillary renal cell carcinoma with low-grade spindle cell foci. A mimic of mucinus tubular and spindle cell carcinoma. Am J Surg Pathol 2008;32:1353-1359.
55. Masson P. Tumeurs Humaines 1955. Human Tumors, Histology, Diagnosis and Technique. Wayne State University Press: Detroit, 1970.
56. Murphy W, Beckwith JB, Farrow GM. Tumors of the Kidney and Bladder. Armed Forces Institute of Pathology: Washington, DC, 1994.
57. MacLennan GT, Bostwick DG. Tubulocystic carcinoma, mucinous tubular and spindle cell carcinoma, and other recently described rare renal tumors. Clin Lab Med 2005;25:393-416.
58. Azoulay S, Vieillefond A, Paraf F, et al. Tubulocystic carcinoma of the kidney: a new entity among renal tumors. Virchows Arch 2007;451:905-909.
59. Yang XJ, Zhou M, Ondrej H, et al. Tubulocystic carcinoma of the kidney. Clinicopathologic and molecular characterization. Am J Surg Pathol 2008;32:177-187.
60. Amin MB, MacLennan GT, Gupta R, et al. Tubulocystic carcinoma of the kidney clinicopathologic analysis of 31 cases of a distinctive rare subtype of renal cell carcinoma. Am J Surg Pathol 2009;33: 384-392.
61. Osunkoya AO, Young AN, Wang W, Netto GJ, Epstein JI. Comparison of gene expression profiles in tubulocystic carcinoma and collecting duct carcinoma of the kidney. Am J Surg Pathol 2009, e-pub ahead of print.
62. Zhou M, Yang Ximing, Lopez JI, et al. Renal tubulocystic carcinoma is closely related to papillary renal cell carcinoma: Implications for pathologic classification. Am J Surg Pathol 2009, e-pub ahead of print.
63. Eble JN, Bonsib SM. Extensively cystic renal neoplasms: Cystic nephroma, cystic partially differential nephroblastoma, multi-locular cyst renal cell carcinoma, and cystic hamartoma of renal pelvis. Semin Diagn Pathol 1998;15:2-20.
64. Adsay NV, Eble JN, Srigley JR, et al. Mixed epithelial stromal tumor of the kidney. Am J Surg Pathol 2000;24:958-970.
65. Leroy X, Aubert S, Lemaitre L, et al. Multilocular cystic renal oncocytoma. J Clin Pathol 2006;59: 223-224.
66. Argani P, Ladanyi M. Recent advances in pediatric renal neoplasia. Adv Anat Pathol 2003;10:243-260.
67. Argani P, Ladanyi M. Translocation carcinoma of the kidney. Clin Lab Med 2005;25:363-378.
68. Bruder E, Passera O, Harms D, et al. Morphologic and molecular characterization of renal cell carcinoma in children and young adults. Am J Surg Pathol 2004;28:1117-1132.
69. Camparo P, Vasiliu V, Molinie V, et al. Renal translocation carcinomas—clinicopathologic, immunohistochemical and gene expression profiling analysis of 31 cases with a review of the literature. Am J Surg Pathol 2008;35:656-670.
70. Argani P, Hawkins A, Griffin CA, et al. A distinctive pediatric renal neoplasm characterized by epithelioid morphology, basement membrane-production, focal HMB45 immunoreactivity, and t(6;11) (p21.1;q12) chromosome translocation. Am J Pathol 2001;158: 2089-2096.
71. Argani P, Lal P, Hutchinson B, et al. Aberrant nuclear immunoreactivity for TFE3 in neoplasms with TFE3 gene fusions: a sensitive and specific immunohistochemical assay. Am J Surg Pathol 2003;27:750-761.
72. Argani P, Antonescu CR, Illei PB, et al. Primary renal neoplasm with the ASPL-TFE3 gene fusion of alveolar soft part sarcoma. A distinctive tumor entity previously included among renal cell carcinomas of children and adolescents. Am J Pathol 2001;159: 179-192.
73. Argani P, Antonescu CR, Couturier J, et al. PRCCTFE3 renal carcinomas. Morphologic, immunohistochemical, ultrastructural and molecular analysis of an entity associated with the t(X;1)(p11.2;q21). Am J Surg Pathol 2002;26:1553-1566.
74. Argani P, Ladanyi M. Distinctive neoplasms characterised by specific chromosomal translocations comprise a significant proportion of pediatric renal cell carcinomas. Pathology 2003;35:492-498.
75. Geller JI, Argani P, Adeniran A, et al. Translocation renal cell carcinoma lack of negative impact due to lymph node spread. Cancer 2008;112: 1607-1616.
76. Dal Cin P, Stas M, Sciot R, et al. Translocation (X:1) reveals metastasis 31 years after renal cell carcinoma. Cancer Genet Cytogenet 1998;101:58-61.
77. Eble JN. Mucinous tubular and spindle cell carcinoma and post-neuroblastoma carcinoma: newly recognised entities in the renal cell carcinoma family. Pathology 2003;35:499-504.
78. Fleitz JM, Wootton-Gorges SL, Wyatt-Ashmead J, et al. Renal cell carcinoma in long-term survivors of advanced stage neuroblastoma in early childhood. Pediatr Radiol 2003;33:540-545.
79. Bassal M, Mertens AC, Taylor L, et al. Risk of selected subsequent carcinomas in survivors of childhood cancer: a report from the childhood cancer survivor study. J Clin Oncol 2006;24:476-483.
80. Medeiros LJ, Palmedo G, Krigman HR, et al. Oncocytoid renal cell carcinoma after neuroblastoma: a report of four cases of a distinct clinicopathologic entity. Am J Surg Pathol 1999;23:772-780.
81. Koyle MA, Hatch DA, Furness PD, et al. Long-term urological complications in survivors younger than 15 months of advanced stage abdominal neuroblastoma. J Urol 2001;166:1455-1458.
82. Dhall D, Al-Ahmadie HA, Dhall G, Shen-Schwarz S, Tickoo SK. Pediatric renal cell carcinoma with oncocytoid features occurring in a child after chemotherapy for cardiac leiomyomasarcoma. Urology 2007;70:178e13-178e15.
83. Tosaka A, Ohya R, Vamada K, et al. Incidence and properties of renal masses and asymptomatic renal cell carcinoma detected by abdominal ultrasonography. J Urol 1990;144:1097-1099.
84. Gehrig JJ, Gottheiner TI, Swenson RS. Acquired cystic disease of the end-stage kidney. Am J Med 1985;79:609-620.
85. Farivar-Mohseni H, Perlmutter AE, Wilson S, et al. Renal cell carcinoma and end stage renal disease. J Urol 2006;175:2018-2021.
86. Stewart JH, Buccianti G, Agodoa L, et al. Cancers of the kidney and urinary tract in patients on dialysis for end stage renal disease: analysis of data from the United States, Europe, and Australia and New Zealand. J Am Soc Nephrol 2003;14: 197-202.
87. Irie K, Ishizuka O, Yokoyama H, Kinebuchi Y, Satoh T, Nishizawa O. Resection of local recurrence of renal cell carcinoma in a hemodialysis patient 6 years after radical nephrectomy. Int J Urol 2004;11: 550-552.
88. Onishi T, Igarashi T, Tobe T, Ichikawa T. A case report of chromophobe cell renal carcinoma arising from atrophic kidney during long-term haemodialysis. Acta Urol Japon 2006;52:919-921.
89. Ianhez LE, Lucon M, Nahas WC, et al. Renal cell carcinoma in renal transplant patients. Urology 2007;69:462-464.
90. Sangoi AR, Higgins JP. Bilateral mixed epithelial stroma tumor in an end-stage renal disease patient: the first case report. Hum Pathol 2008;39:142-146.
91. Hamamoto S, Okamura T, Mizunok, et al. Renal oncocytoma with bilateral synchronous renal cell carcinoma in a patient undergoing long term dialysis. Int J Urol 2008;15:87-89.
92. Nishihara K, Shomori K, Nagashima Y, et al. Chromophobe renal cell carcinoma and ‘capsulomas’ with acquired cystic disease of the kidney in a long-term hemodialysis patient. Int J Urol 2008;15: 543-545.
93. Sakura M, Masuda H, Saitok, et al. Collecting duct carcinoma with acquired cystic disease of the kidney in a long-term hemodialysis patient. Int J Urol 2008;15:93-94.
94. Martin M, De Castro Olmedo C, Torrecilla Garcia-Ripoli JR, et al. Low grade collecting duct carcinoma of the kidney in a patient treated by dialysis. Acta Urol Espanol 2008;32:559-562.
95. Hora M, Hes O, Reischig T, et al. Tumors in end-stage kidneys. Transplant Proc 2008;40:3354-3358.
96. Tickoo SK, de Peralta-Venturina MN, Harik LR, et al. Spectrum of epithelial disease. An experience from 66 tumor-bearing kidneys with emphasis on histologic patterns distinct from those in sporadic adult renal neoplasia. Am J Surg Pathol 2006;30: 141-153.
97. Kuroda N, Tamura M, Taguchi T, et al. Sarcomatoid acquired cystic disesase-associated renal cell carcinoma. Histol Histopathol 2008;23: 1327-1331.
98. Yoshida M, Yao M, Ishikawa I, et al. Somatic von Hippel-Lindau disease gene mutation in clear cell renal carcinomas associated with end-stage renal disease/acquired cystic diseases of the kidney. Genes Chromosomes Cancer 2002;35:359-364.
99. Inone H, Nonomura N, Kojima Y, et al. Somatic mutations of the von Hippel-Lindau disease gene in renal carcinomas occurring in patients with longterm dialysis. Nephrol Dial Transplant 2007;22: 2052-2055.
100. Cheuk W, Lo ES, Chan AK, Chan JK. Atypical epithelial proliferations in acquired renal cystic disease harbor cytogenetic alterations. Hum Pathol 2002;33:761-765.
101. Cossu-Rocca P, Eble JN, Zhang S, et al. Acquired cystic disease—associated renal tumors: an immunohistochemical and fluorescence in situ hybridization study. Mod Pathol 2006;19:780-787.
102. Amin MB, Michal M, Radhakrishnan A, et al. Primary thyroid-like follicular carcinoma of the kidney: a histologically distinctive primary renal epithelial tumor. Mod Pathol 2004;17:137A.
103. Jung SJ, Chung JI, Park SH, et al. Thyroid follicular carcinoma-like tumor of kidney: a cases report with morphologic, immunohistochemical and genetic analysis. Am J Surg Pathol 2006;30:411-415.
104. Amin MB, Gupta R, Ondrej H, et al. Primary thyroidlike follicular carcinoma of the kidney. Report of 6 cases of a histologically distinctive adult renal epithelial neoplasm. Am J Surg Pathol 2009;33: 393-400.
105. Gobbo S, Eble JN, Grignon DJ, et al. Clear cell papillary renal cell carcinoma. A distinct histopathologic and molecular genetic entity. Am J Surg Pathol 2008;32:1239-1245.
106. Delahunt B, Eble JN. Papillary renal cell carcinoma in Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs In: Eble JN, Sauter G, Epstein JI and Sesterhenn IA (eds). World Health Organization Classification of Tumours. IARC: Lyon, 2004, pp 27-29.
107. Delahunt B, Eble JN. Papillary renal cell carcinoma: a clinicopathologic and immunohistochemical study of 105 tumors. Mod Pathol 1997;10:537-544.
108. Lefevre M, Couturiere J, Sibony M, et al. Adult papillary renal tumor with oncocytic cells: clincopathologic, immunohistochemical, and cytogenetic features of 10 cases. Am J Surg Pathol 2005;29: 1576-1581.
109. Masuzawa N, Kishimoto M, Nishimura A, Shichiri Y, Yanagisawa A. Oncocytic renal cell carcinoma having papillotubular growth: Rare morphological variant of papillary renal cell carcinoma. Path Int 2008;58: 300-305.
110. Lakshmi P, Kunju, Wojno K, et al. Papillary renal cell carcinoma with oncocytic cells and nonoverlapping low grade nuclei: expanding the morphologic spectrum with emphasis on clinicopathologic, immunohistochemical and molecular features. Hum Pathol 2008;39:96-101.
111. Hes O, Burnelli M, Michal M, et al. Oncocytic papillary renal cell carcinoma: a clinicopathologic immunohistochemical, ultrastructural, and interphase cytogenetic study of 12 cases. Ann Diagn Pathol 2006;10:133-139.
112. Mai KT, Kohler DM, Roberston SJ, Belanger EC, Marginean EC. Oncocytic papillary renal cell carcinoma with solid architecture: mimic of renal oncocytoma. Path Int 2008;58:164-168.
113. Kuhn E, De Anda J, Manoni S, Netto G, Rosai J. Renal cell carcinoma associated with prominent angioleiomyoma-like proliferation. Report of 5 cases and review of the literature. Am J Surg Pathol 2006;30: 1372-1381.
114. Honey RJ, Honey RM. Tuberous sclerosis and bilateral renal carcinoma. Br J Urol 1977;49:441-446.
115. Govaerts JJ, van Gooswilligen JC, Vooys GP, et al. Renal hamartoma associated with renal cell (Grawitz) tumor: another indication that Grawitz tumors are carcinosarcomas. Eur Urol 1987;13:276-280.
116. Canzonieri V, Volpe R, Gloghini A, et al. Mixed renal tumor with carcinomatous and fibroleiomyomatous components, associated with angiomyolipoma in the same kidney. Pathol Res Pract 1993;189: 951-959.
117. Michal M, Hes O, Havlicek F. Benign renal angiomyoadenomatous tumor: a previously unreported renal tumor. Ann Diagn Pathol 2000;4:311-315.
118. Brunelli M, Menestrina F, Segala D, et al. Renal cell carcinoma associated with prominent leiomyomatous proliferation appears not to be a variant of clear cell renal cell carcinoma. Mod Pathol 2009;22: 160A-161A.
119. Shannon BA, Cohen RG, Segal A, Baker EG, Murch AR. Clear cell renal cell carcinoma with smooth muscle stroma. Hum Pathol 2009;40:425-429.